应激相关心房颤动的结局与管理:JACC最新综述
应激相关心房颤动定义为在急性可逆性生理应激(如心脏手术、急性感染)背景下新发的心房颤动。尽管传统上被视为短暂且良性,但越来越多证据表明其具有重要预后意义,长期房颤复发率和房颤相关不良事件(如卒中、心力衰竭)接近无应激诱因的房颤。本文综述其流行病学、机制、结局和管理,提出病理生理框架,并强调未来精准管理的研究方向。
要点
- 应激相关房颤并非良性,长期复发和不良事件风险接近无诱因房颤。
- 管理策略(预防、监测、治疗)差异大,需基于病理生理框架个体化。
- 强烈潜在易感性者复发风险高,而严重应激无易感性者复发风险低。
核心结论
- 应激相关房颤具有重要预后意义,长期房颤复发和房颤相关不良事件发生率接近无应激诱因的房颤。
研究设计与样本
- 本文为JACC最新综述,基于现有证据对文献进行临床导向的综合。
主要发现
- 应激相关房颤的长期房颤复发率和房颤相关不良事件(如卒中、心力衰竭)接近无应激诱因的房颤。
- 应激相关房颤的管理(预防、监测、治疗)存在高度差异。
- 在强烈潜在易感性背景下发生的应激相关房颤(有时称为「诱发性房颤」)复发风险较高。
- 在严重生理应激且无或极少潜在易感性情况下发生的房颤(有时称为「可逆性房颤」)复发风险较低。
- 以心脏术后应激相关房颤为例,局部炎症等机制的理解已转化为降低发生率的新干预(如后心包切开术)。
临床怎么用
- 应将应激相关房颤视为具有潜在长期风险的疾病,而非短暂良性现象。
- 管理需综合评估应激因素与潜在易感性,以制定个体化预防、监测和治疗策略。
- 对于强烈易感性者的应激相关房颤,应警惕高复发风险并加强随访。
局限性
- 本文为综述,未报告原始研究的具体样本量、阈值或效应值。
- 应激相关房颤管理的关键方面(预防、监测、治疗)仍存在高度差异,证据尚不统一。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Stressor-associated atrial fibrillation (AF) is defined as new onset AF occurring in the setting of an acute and reversible physiologic stressor (eg, cardiac surgery, acute infection). Although historically viewed as transient and potentially benign, a growing body of evidence demonstrates that stressor-associated AF is prognostically important, with long-term rates of AF recurrence and AF-related adverse events (eg, stroke, heart failure) approaching those of AF occurring without a stressor. Nevertheless, key aspects of stressor-associated AF management (eg, prevention, surveillance, treatment) remain highly variable. In this state-of-the-art review, we provide a clinically oriented synthesis of the epidemiology, mechanisms, outcomes, and management of stressor-associated AF across the breadth of characterized precipitants. Within this context, we outline a pathophysiologic framework in which stressor-associated AF represents a spectrum spanning variable relative contributions of direct stressor effects, stressor-mediated substrate, and underlying predisposition (ie, modifiable and nonmodifiable AF risk factors). Stressor-associated AF episodes occurring in the setting of a strong underlying predisposition to AF (sometimes termed "provoked AF") have a higher risk of recurrence, while episodes occurring in response to a profound physiologic stressor with minimal or no underlying predisposition (sometimes termed "reversible AF") have a lower risk of recurrence. Using postcardiac surgery stressor-associated AF as an exemplar, we summarize recent advances translating greater pathophysiologic understanding (eg, role of local inflammation) into novel clinical interventions capable of reducing stressor-associated AF incidence (eg, posterior pericardiotomy). We summarize available evidence for clinical management of stressor-associated AF and offer a conceptual framework to inform care. Finally, we conclude by outlining key priorities for future research designed to facilitate precision management of stressor-associated AF, including identification of more effective preventive measures, development of models to stratify risk of recurrent AF and AF-related adverse events following a stressor-associated AF episode, and integration of patient-centered outcomes.
引用
- Haimovich, Kany, Ajufo, et al. Outcomes and Management of Stressor-Associated Atrial Fibrillation: JACC State-of-the-Art Review. J Am Coll Cardiol. 2025. PMID: 40962378. doi:10.1016/j.jacc.2025.07.031
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。